References
- Sheriff T, Lin MJ, Dubin D, et al. The potential role of cannabinoids in dermatology. J Dermatolog Treat. 2019:1–7. DOI:10.1080/09546634.2019.1675854
- Barrientos S, Stojadinovic O, Golinko MS, et al. Growth factors and cytokines in wound healing. Wound Repair Regen. 2008;16(5):585–601.
- Krishnaswamy VR, Mintz D, Sagi I. Matrix metalloproteinases: the sculptors of chronic cutaneous wounds. Biochim Biophys Acta Mol Cell Res. 2017;1864(11):2220–2227.
- Keshavarz M, Norooznezhad AH, Mansouri K, et al. (JWH-133) therapy could be effective for treatment of corneal neovascularization. Iran J Med Hypotheses Ideas. 2010;4(4):3.
- Norooznezhad AH, Norooznezhad F. Cannabinoids: possible agents for treatment of psoriasis via suppression of angiogenesis and inflammation. Med Hypotheses. 2017;99:15–18.
- Wang L-L, Zhao R, Li J-Y, et al. Pharmacological activation of cannabinoid 2 receptor attenuates inflammation, fibrogenesis, and promotes re-epithelialization during skin wound healing. Eur J Pharmacol. 2016;786:128–136.
- Du Y, Ren P, Wang Q, et al. Cannabinoid 2 receptor attenuates inflammation during skin wound healing by inhibiting M1 macrophages rather than activating M2 macrophages. J Inflamm. 2018;15(1):25.
- Suschek CV, Schnorr O, Kolb-Bachofen V. The role of iNOS in chronic inflammatory processes in vivo: is it damage-promoting, protective, or active at all? CMM. 2004;4(7):763–775.
- Appendino G, Gibbons S, Giana A, et al. Antibacterial cannabinoids from Cannabis sativa: a structure − activity study. J Nat Prod. 2008;71(8):1427–1430.